US BROKER MOVES: PANW double upgraded at Arete; SABR downgraded at Bernstein

UPGRADES

1stdibs (DIBS) upgraded from Market Perform to Outperform at Northland
Innovative Industrial Properties (IIPR) upgraded from Sell to Neutral at Compass Point; PT USD 45
Palo Alto Networks (PANW) upgraded from Sell to Buy at Arete; PT USD 185
Unity Software (U) upgraded from Underperform to Neutral at BofA Securities; PT USD 19 (prev. USD 18)
Block (XYZ) upgraded from Hold to Buy at HSBC; PT USD 77 (prev. USD 70)

DOWNGRADES

AES Corp (AES) downgraded from Outperform to Neutral at Mizuho; PT USD 15 (prev. USD 16)
DHT Holdings (DHT) downgraded from Buy to Hold at DNB Carnegie
Mosaic (MOS) downgraded from Overweight to Equalweight at Barclays; PT USD 31
uniQure (QURE) downgraded from Outperform to Neutral at Mizuho; PT USD 12 (prev. USD 33)
uniQure (QURE) downgraded from Overweight to Equal Weight at Wells Fargo; PT USD 15 (prev. USD 60)
Sabre (SABR) downgraded from Outperform to Market Perform at Bernstein SocGen; PT USD 1.50
Select Medical (SEM) downgraded from Outperform to Sector Perform at RBC Capital; PT USD 16.50 (prev. USD 19.00)
BlackRock TCP Capital (TCPC) downgraded from Market Perform to Underperform at KBW; PT USD 3.50 (prev. USD 7.00)
Grupo Televisa (TV) downgraded from Overweight to Neutral at JPMorgan

INITIATIONS

Agios Pharmaceuticals (AGMB) initiated at Outperform at Leerink Partners; PT USD 36
Agios Pharmaceuticals (AGMB) initiated at Overweight at Morgan Stanley; PT USD 28
Agios Pharmaceuticals (AGMB) initiated at Overweight at JPMorgan; PT USD 32
Amylyx Pharmaceuticals (AMLX) initiated at Buy at Stifel; PT USD 21
Carpenter Technology (CRS) initiated at Positive at Susquehanna; PT USD 470
Healthcare Services Group (HCSG) initiated at Sector Perform at RBC Capital; PT USD 22
IQVIA (IQV) initiated at Outperform at RBC Capital; PT USD 221
Luckin Coffee (LKNCY) initiated at Add at China Galaxy International; PT USD 52
Medpace (MEDP) initiated at Outperform at RBC Capital; PT USD 522
Oportun Financial (OFRM) initiated at Buy at BofA Securities; PT USD 26
Oportun Financial (OFRM) initiated at Buy at Goldman Sachs; PT USD 43
Oportun Financial (OFRM) initiated at Equalweight at Barclays; PT USD 25
Oportun Financial (OFRM) initiated at Hold at Deutsche Bank; PT USD 25
Oportun Financial (OFRM) initiated at Hold at TD Cowen; PT USD 26
Oportun Financial (OFRM) initiated at In Line at Evercore ISI; PT USD 26
Oportun Financial (OFRM) initiated at Outperform at Oppenheimer
Oportun Financial (OFRM) initiated at Outperform at William Blair
Oportun Financial (OFRM) initiated at Overweight at JPMorgan; PT USD 29
Ormat Technologies (ORA) initiated at Outperform at RBC Capital; PT USD 130
Sagimet Biosciences (SGP) initiated at Buy at Citi; PT USD 42
Sagimet Biosciences (SGP) initiated at Buy at Stifel; PT USD 42
Sagimet Biosciences (SGP) initiated at Buy at Jefferies; PT USD 62
Sagimet Biosciences (SGP) initiated at Outperform at Leerink Partners; PT USD 42